Raphael Clynes

Raphael Clynes is currently a board member at Chameleon Biosciences. Prior to that, they were the Vice President Translational Biology at Xencor for 5 years. Raphael also served as a board member at Targovax ASA for 3 months. Raphael has also worked as the Group Medical Director & Scientific Director Human Immunology at Bristol-Myers Squibb for 3 years. Before that, they were an Associate Professor at Columbia University Medical Center for 15 years. Raphael started their career as a Clinical Instructor at Memorial Sloan Kettering Cancer Center for 3 years.

Raphael Clynes has a MD, PhD from Stony Brook University, a Bachelor’s degree from the Massachusetts Institute of Technology, and is Board Certified in Hematology/Oncology from the American Board of Internal Medicine. Raphael did their fellowship in Medical Oncology/Hematology at Memorial Sloan Kettering Cancer Center and their residency in Internal Medicine at Washington University in St. Louis.